The Iranian researchers at Ibn-e Sina Academy Research Center (ISARC) in collaboration with their Dutch counterparts managed to propagate spermatogonial stem cells for the first time in the world. The announcement was made by ISARC\'s Medical Education Secretary Hooman Sadri Ardekani on Saturday. Ardekani said young boys treated with high-dose chemotherapy for cancer often face infertility once they reach adulthood. Cryopreserving testicular tissue before chemotherapy and autotransplantation of spermatogonial stem cells at a later stage could theoretically allow for restoration of fertility, he added. Elaborating on the procedure of the study, he said that the research was performed from 2007 to 2011 using testis material donated by males. Expression of spermatogonial markers on both the RNA and protein level was maintained throughout the entire culture period, he added. In recent years, Iran has made giant progress in stem cell science and is now revered as a world pioneering country in the area. Iran has also taken wide strides in other areas of medical science as well and is now producing unique drugs and medication for several types of cancer and AIDS.
GMT 14:01 2018 Thursday ,30 August
Expat with rare heart disorder gets life-saving surgeryGMT 00:18 2018 Tuesday ,23 January
Boy with 10-pound tumour on face diesGMT 21:23 2018 Monday ,22 January
All set for first global medical tourism conference in DubaiGMT 22:46 2018 Sunday ,21 January
Second face transplant for FrenchmanGMT 07:51 2018 Saturday ,20 January
Trio aquitted of negligence in Canada railway disasterGMT 10:57 2018 Thursday ,18 January
Breastfeeding for 6 months cuts diabetes risk in half: studyGMT 16:10 2018 Wednesday ,17 January
Child mummy in Italy had hepatitis, not smallpoxGMT 18:36 2018 Tuesday ,16 January
Greece strikes cause transport chaos, healthcare delays

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor